Actuate Therapeutics inks $21.7 mln Series B

Fort Worth, Texas-based Actuate Therapeutics Inc, a clinical stage biopharmaceutical company, has raised $21.7 million in Series B financing. Kairos Ventures led the round with participation from DEFTA Partners, Tech Coast Angels and Bios Partners.

Source: Press Release

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!